Gilead won a valuable FDA voucher with its Veklury approval, but patient advocates are urging the company to […]
Bayer, ViiV and RB challenge limits of pharma marketing creativity with innovative thinking, executions and media bbulik Mon, […]
A new study has demonstrated that using the ‘wisdom of crowds’ (also known as collective intelligence) of three […]
Older patients are typically sedentary, you assume—without realising it. A patient you relate to well receives that bit […]
I’m proud to be a GP. It’s one of the hardest and most worthwhile medical specialties. I’ve seen […]
In pre-covid days, I would walk out to the waiting room to fetch each patient. This benefited my […]
Three experts with widely differing viewpoints regarding appropriate public health measures to control the spread of covid-19 weighed […]
Gilead and Galapagos’ application for oral JAK1 inhibitor validated by agency
Partnership aims to advance disease severity testing programme for COVID-19
Data presented at virtual European Academy of Dermatology and Venereology congress